###begin article-title 0
###xml 49 54 <span type="species:ncbi:9606">human</span>
Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific
###end article-title 0
###begin p 1
###xml 1126 1127 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 802 807 <span type="species:ncbi:9606">human</span>
###xml 1047 1052 <span type="species:ncbi:9606">human</span>
###xml 1242 1247 <span type="species:ncbi:9606">human</span>
Accumulation of triacylglycerol (TAG) and lipid intermediates in skeletal muscle plays an important role in the etiology of insulin resistance and type 2 diabetes mellitus. Disturbances in skeletal muscle lipid turnover and lipolysis may contribute significantly to this. So far, knowledge on the regulation of muscle lipolysis is limited. Recently the identification of a new lipase was reported: adipose triglyceride lipase (ATGL). ATGL deficient animals show significant lipid accumulation in skeletal muscle, which may indicate that ATGL plays a pivotal role in skeletal muscle lipolysis. However, until now, it is still unknown whether ATGL protein is expressed in human skeletal muscle. Therefore, the aim of the present study was to investigate whether ATGL is expressed at the protein level in human skeletal muscle, and to examine whether its expression is fiber-type specific. To accomplish this, we established an imunohistochemical and immunofluorescent staining procedure to study ATGL protein expression in relation to fiber type in human vastus lateralis muscle of eight male subjects (BMI range: 21.0-34.5 kg/m2 and age: 38-59 years). In the present paper we report for the first time that ATGL protein is indeed expressed in human skeletal muscle. Moreover, ATGL is exclusively expressed in type I (oxidative) muscle fibers, suggesting a pivotal role for ATGL in intramuscular fatty acid handling, lipid storage and breakdown.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2006</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2004</xref>
###xml 1173 1177 1173 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1999</xref>
###xml 1219 1223 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2004</xref>
###xml 1500 1504 1500 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2004</xref>
###xml 1719 1723 1719 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2006</xref>
###xml 1803 1808 <span type="species:ncbi:9606">human</span>
###xml 1935 1940 <span type="species:ncbi:9606">human</span>
###xml 2094 2099 <span type="species:ncbi:9606">human</span>
###xml 2284 2289 <span type="species:ncbi:9606">human</span>
The prevalence of obesity and type 2 diabetes mellitus has reached epidemic proportions both in developing as well as developed countries. More information is required on the etiology of obesity and insulin resistance to improve nutritional recommendations and/or to identify new targets for pharmacological interventions. Recent evidence indicates that increased storage of triacylglycerol (TAG) and lipid intermediates in non-adipose tissues (i.e. ectopic fat deposition), such as skeletal muscle plays an important role in the etiology of insulin resistance and type 2 diabetes mellitus (Petersen and Shulman 2006). Disturbances in the breakdown of stored fat (endogenous lipolysis) may be a factor contributing to an increased fat storage in the form of intramuscular triacylglycerol (IMTG) and lipid intermediates (e.g. diacylglycerol (DAG), long-chain fatty-acyl CoA and ceramides) (Blaak et al. 2004). The enzymatic regulation of lipolysis in skeletal muscle is poorly understood, even in healthy volunteers. The general view is that fat stores can be mobilized by hormone-sensitive lipase (HSL), which is controlled by the action of catecholamines (Langfort et al. 1999) and muscle contraction (Langfort et al. 2000). Recently the identification of a new lipase that is primarily responsible for the hydrolysis of TAG was reported, namely adipose triglyceride lipase (ATGL) (Zimmermann et al. 2004). ATGL mRNA expression has been demonstrated in skeletal muscle of rodents (Zimmermann et al. 2004). Interestingly, this lipase may play a pivotal role in skeletal muscle lipolysis, since ATGL deficient animals show significant TAG accumulation in non-adipose tissues, including skeletal muscle (Haemmerle et al. 2006). However, until now, it is still unknown whether ATGL protein is expressed in human skeletal muscle. Therefore, the aim of the present study was to investigate whether ATGL is expressed at the protein level in human skeletal muscle. In addition, we examined whether ATGL protein expression is fiber type-specific to obtain better insight into its physiological role in human skeletal muscle. To accomplish this we established a combined immunohistochemical an immunofluorescent staining procedure to study ATGL protein expression in relation to fiber type in human vastus lateralis muscle.
###end p 4
###begin title 5
Materials and methods
###end title 5
###begin title 6
Subjects
###end title 6
###begin p 7
###xml 69 72 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 242 243 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 274 275 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 392 393 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1134 1138 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2007</xref>
###xml 1244 1246 1236 1238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IR</sub>
###xml 1325 1329 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1985</xref>
###xml 1595 1602 1587 1594 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1602 1650 1594 1642 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="8">Athropometric and clinical data for the subjects</p>
###xml 1602 1650 1594 1642 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="8">Athropometric and clinical data for the subjects</p></caption>
###xml 1650 1651 1642 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1650 1651 1642 1643 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic></th>
###xml 1651 1688 1643 1680 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Eight men (three lean and five obese)</th>
###xml 1650 1688 1642 1680 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"><italic>n</italic></th><th align="left">Eight men (three lean and five obese)</th></tr>
###xml 1650 1688 1642 1680 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"><italic>n</italic></th><th align="left">Eight men (three lean and five obese)</th></tr></thead>
###xml 1688 1698 1680 1690 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age (year)</td>
###xml 1698 1714 1690 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">50&#160;&#177;&#160;3 (38&#8211;59)</td>
###xml 1688 1714 1680 1704 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age (year)</td><td char="&#177;" align="char">50&#160;&#177;&#160;3 (38&#8211;59)</td></tr>
###xml 1723 1724 1713 1714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1714 1725 1704 1715 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMI (kg/m<sup>2</sup>)</td>
###xml 1725 1749 1715 1737 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">28.9&#160;&#177;&#160;1.9 (21.0&#8211;34.5)</td>
###xml 1714 1749 1704 1737 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.9 (21.0&#8211;34.5)</td></tr>
###xml 1749 1752 1737 1740 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">%BF</td>
###xml 1752 1776 1740 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">28.9&#160;&#177;&#160;1.7 (22.2&#8211;34.2)</td>
###xml 1749 1776 1737 1762 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">%BF</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.7 (22.2&#8211;34.2)</td></tr>
###xml 1776 1783 1762 1769 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">FM (kg)</td>
###xml 1783 1807 1769 1791 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">26.6&#160;&#177;&#160;3.1 (16.5&#8211;40.3)</td>
###xml 1776 1807 1762 1791 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">FM (kg)</td><td char="&#177;" align="char">26.6&#160;&#177;&#160;3.1 (16.5&#8211;40.3)</td></tr>
###xml 1807 1815 1791 1799 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">FFM (kg)</td>
###xml 1815 1839 1799 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">65.2&#160;&#177;&#160;2.8 (53.3&#8211;77.6)</td>
###xml 1807 1839 1791 1821 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">FFM (kg)</td><td char="&#177;" align="char">65.2&#160;&#177;&#160;2.8 (53.3&#8211;77.6)</td></tr>
###xml 1839 1842 1821 1824 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">WHR</td>
###xml 1842 1867 1824 1847 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.96&#160;&#177;&#160;0.02 (0.85&#8211;1.06)</td>
###xml 1839 1867 1821 1847 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">WHR</td><td char="&#177;" align="char">0.96&#160;&#177;&#160;0.02 (0.85&#8211;1.06)</td></tr>
###xml 1867 1873 1847 1853 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">HOMAir</td>
###xml 1873 1895 1853 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">3.05&#160;&#177;&#160;0.4 (1.6&#8211;4.1)</td>
###xml 1867 1895 1847 1873 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">HOMAir</td><td char="&#177;" align="char">3.05&#160;&#177;&#160;0.4 (1.6&#8211;4.1)</td></tr>
###xml 1688 1895 1680 1873 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Age (year)</td><td char="&#177;" align="char">50&#160;&#177;&#160;3 (38&#8211;59)</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.9 (21.0&#8211;34.5)</td></tr><tr><td align="left">%BF</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.7 (22.2&#8211;34.2)</td></tr><tr><td align="left">FM (kg)</td><td char="&#177;" align="char">26.6&#160;&#177;&#160;3.1 (16.5&#8211;40.3)</td></tr><tr><td align="left">FFM (kg)</td><td char="&#177;" align="char">65.2&#160;&#177;&#160;2.8 (53.3&#8211;77.6)</td></tr><tr><td align="left">WHR</td><td char="&#177;" align="char">0.96&#160;&#177;&#160;0.02 (0.85&#8211;1.06)</td></tr><tr><td align="left">HOMAir</td><td char="&#177;" align="char">3.05&#160;&#177;&#160;0.4 (1.6&#8211;4.1)</td></tr></tbody>
###xml 1650 1895 1642 1873 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"><italic>n</italic></th><th align="left">Eight men (three lean and five obese)</th></tr></thead><tbody><tr><td align="left">Age (year)</td><td char="&#177;" align="char">50&#160;&#177;&#160;3 (38&#8211;59)</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.9 (21.0&#8211;34.5)</td></tr><tr><td align="left">%BF</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.7 (22.2&#8211;34.2)</td></tr><tr><td align="left">FM (kg)</td><td char="&#177;" align="char">26.6&#160;&#177;&#160;3.1 (16.5&#8211;40.3)</td></tr><tr><td align="left">FFM (kg)</td><td char="&#177;" align="char">65.2&#160;&#177;&#160;2.8 (53.3&#8211;77.6)</td></tr><tr><td align="left">WHR</td><td char="&#177;" align="char">0.96&#160;&#177;&#160;0.02 (0.85&#8211;1.06)</td></tr><tr><td align="left">HOMAir</td><td char="&#177;" align="char">3.05&#160;&#177;&#160;0.4 (1.6&#8211;4.1)</td></tr></tbody></table>
###xml 1895 1957 1873 1933 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="9">Data are presented as mean&#160;&#177;&#160;standard error (SE) and (range)</p>
###xml 1957 1958 1933 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1979 1982 1955 1958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMI</italic>
###xml 2000 2003 1976 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">%BF</italic>
###xml 2025 2027 2001 2003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FM</italic>
###xml 2038 2041 2014 2017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FFM</italic>
###xml 2057 2060 2033 2036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WHR</italic>
###xml 2081 2087 2057 2063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HOMAir</italic>
###xml 1957 2139 1933 2115 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="10"><italic>n</italic> Number of subjects, <italic>BMI</italic> body mass index, <italic>%BF</italic> percentage body fat, <italic>FM</italic> fat mass, <italic>FFM</italic> fat-free Mass, <italic>WHR</italic> waist-to-hip ratio, <italic>HOMAir</italic> homeostasis model assessment for insulin resistance</p>
###xml 1895 2139 1873 2115 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="9">Data are presented as mean&#160;&#177;&#160;standard error (SE) and (range)</p><p textid="10"><italic>n</italic> Number of subjects, <italic>BMI</italic> body mass index, <italic>%BF</italic> percentage body fat, <italic>FM</italic> fat mass, <italic>FFM</italic> fat-free Mass, <italic>WHR</italic> waist-to-hip ratio, <italic>HOMAir</italic> homeostasis model assessment for insulin resistance</p></table-wrap-foot>
###xml 1595 2139 1587 2115 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="8">Athropometric and clinical data for the subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>n</italic></th><th align="left">Eight men (three lean and five obese)</th></tr></thead><tbody><tr><td align="left">Age (year)</td><td char="&#177;" align="char">50&#160;&#177;&#160;3 (38&#8211;59)</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.9 (21.0&#8211;34.5)</td></tr><tr><td align="left">%BF</td><td char="&#177;" align="char">28.9&#160;&#177;&#160;1.7 (22.2&#8211;34.2)</td></tr><tr><td align="left">FM (kg)</td><td char="&#177;" align="char">26.6&#160;&#177;&#160;3.1 (16.5&#8211;40.3)</td></tr><tr><td align="left">FFM (kg)</td><td char="&#177;" align="char">65.2&#160;&#177;&#160;2.8 (53.3&#8211;77.6)</td></tr><tr><td align="left">WHR</td><td char="&#177;" align="char">0.96&#160;&#177;&#160;0.02 (0.85&#8211;1.06)</td></tr><tr><td align="left">HOMAir</td><td char="&#177;" align="char">3.05&#160;&#177;&#160;0.4 (1.6&#8211;4.1)</td></tr></tbody></table><table-wrap-foot><p textid="9">Data are presented as mean&#160;&#177;&#160;standard error (SE) and (range)</p><p textid="10"><italic>n</italic> Number of subjects, <italic>BMI</italic> body mass index, <italic>%BF</italic> percentage body fat, <italic>FM</italic> fat mass, <italic>FFM</italic> fat-free Mass, <italic>WHR</italic> waist-to-hip ratio, <italic>HOMAir</italic> homeostasis model assessment for insulin resistance</p></table-wrap-foot></table-wrap>
###xml 900 912 <span type="species:ncbi:9606">participants</span>
###xml 1657 1660 <span type="species:ncbi:9606">men</span>
Skeletal muscle biopsies were taken under local anesthesia (Xylocaine(R), AstraZeneca BV, Zoetermeer, The Netherlands) by needle biopsy from the vastus lateralis muscle of eight male subjects after an overnight fast. Three lean (BMI < 25 kg/m2) and five obese (BMI > 30 kg/m2) male subjects participated in this study. Anthropometric and clinical data of the subjects are summarized in Table 1. Muscle tissue was immediately frozen in isopentane, followed by liquid nitrogen, and stored at -80degreesC until further analysis. All subjects were asked to refrain from drinking alcohol and to perform no strenuous exercise for a period of 24 h prior to the biopsy. After subjects voided their bladder body weight was determined on a calibrated electronic scale, accurate to 0.1 kg. Waist and hip circumference measurements to the nearest 1 cm were made midway between the lower rib and iliac crest with participants standing upright. Body weight and body density (by hydrostatic weighing) used for calculations of percentage body fat (%BF), fat mass (FM) and fat-free mass (FFM), were determined as previously described (Goossens et al. 2007). Insulin sensitivity was assessed by the homeostasis model assessment index for insulin resistance (HOMAIR), calculated from fasting glucose and insulin concentrations (Matthews et al. 1985). The Medical Ethical Review Committee of Maastricht University approved the study protocol and the clinical investigations were performed according to the Declaration of Helsinki. All subjects gave their written informed consent before participating in the study. Table 1Athropometric and clinical data for the subjectsnEight men (three lean and five obese)Age (year)50 +/- 3 (38-59)BMI (kg/m2)28.9 +/- 1.9 (21.0-34.5)%BF28.9 +/- 1.7 (22.2-34.2)FM (kg)26.6 +/- 3.1 (16.5-40.3)FFM (kg)65.2 +/- 2.8 (53.3-77.6)WHR0.96 +/- 0.02 (0.85-1.06)HOMAir3.05 +/- 0.4 (1.6-4.1)Data are presented as mean +/- standard error (SE) and (range)n Number of subjects, BMI body mass index, %BF percentage body fat, FM fat mass, FFM fat-free Mass, WHR waist-to-hip ratio, HOMAir homeostasis model assessment for insulin resistance
###end p 7
###begin p 8
Athropometric and clinical data for the subjects
###end p 8
###begin p 9
Data are presented as mean +/- standard error (SE) and (range)
###end p 9
###begin p 10
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMI</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">%BF</italic>
###xml 68 70 68 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FM</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FFM</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WHR</italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HOMAir</italic>
n Number of subjects, BMI body mass index, %BF percentage body fat, FM fat mass, FFM fat-free Mass, WHR waist-to-hip ratio, HOMAir homeostasis model assessment for insulin resistance
###end p 10
###begin title 11
Biochemical analysis
###end title 11
###begin p 12
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
A fasting venous blood sample was collected in tubes containing EDTA as anti-coagulant and centrifuged for 10 min at 1,000g, 4degreesC. The plasma was used for the enzymatic colorimetric quantification of glucose concentration (ABX Diagnostics, Montepellier, France) on a COBAS MIRA automated spectrophotometer (Roche Diagnostica, Basel, Switzerland). Plasma insulin was measured with a double antibody radioimmunoassay (Linco Research Inc., St. Charles, Missouri, USA).
###end p 12
###begin title 13
Immunostaining and immunofluorescence protocol
###end title 13
###begin p 14
###xml 366 367 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 368 369 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1016 1017 1015 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1018 1019 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1347 1351 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1993</xref>
###xml 514 519 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:9823">swine</span>
###xml 653 659 <span type="species:ncbi:9986">rabbit</span>
###xml 1225 1230 <span type="species:ncbi:9606">human</span>
###xml 1301 1306 <span type="species:ncbi:9606">human</span>
###xml 1470 1474 <span type="species:ncbi:9925">goat</span>
###xml 1480 1485 <span type="species:ncbi:10090">mouse</span>
###xml 1550 1554 <span type="species:ncbi:9925">goat</span>
###xml 1560 1565 <span type="species:ncbi:10090">mouse</span>
###xml 2047 2053 <span type="species:ncbi:9606">person</span>
Transverse serial sections (10 mum) were cut from each biopsy and each section was placed on a glass slide (Menzel GmbH & CoKG, Braunschweig, Germany) and air dried at room temperature. Skeletal muscle ATGL protein expression and fiber type were investigated by means of a combined immunostaining and immunofluorescence protocol. The sections were fixed using 0.3% H2O2 in methanol. After washing with phosphate buffered saline (PBS) the sections were incubated overnight with a polyclonal antibody raised against human ATGL (Cayman Chemical, Michigan, USA) in PBS at room temperature. Thereafter, slides were incubated with a biotin labeled swine-anti-rabbit secondary antibody (DAKO, Glostrup, Denmark). Subsequently, slides were washed with 0.05% Tween in PBS and incubated with the ABC peroxidase kit (Vectastain Elite PK610, Vector, Burlingame, California). The ATGL immunostaining was visualized with diaminobenzidin (DAB) solution (Fluka Chemie, GmbH, Buchs, Germany) diluted in 0.05M Tris, pH 7.6 and 0.03% H2O2. Coloring was followed by microscope and stopped with water. For determining muscle fiber type the same slides were briefly washed in PBS and then incubated with a monoclonal antibody raised against adult human slow myosin heavy chain and a monoclonal antibody reactive with adult human fast IIa myosin heavy chain (Cho et al. 1993). The antibodies were diluted in PBS and incubated at room temperature. The following secondary antibodies were used: goat anti-mouse IgM conjugated with Alexa Fluor 555 (red) (GAMIgM-Alexa555) and goat anti-mouse IgG1 conjugated with Alexa Fluor 488 (green) (GAMIgG1-Alexa488; Molecular Probes Europe, Leiden, The Netherlands), diluted in PBS and incubated at room temperature. Finally, nuclei were colored using Haematoxilin and slides were included in Mowiol (Merck Chemicals Ltd., Nottingham, UK). Sections were viewed and photographed using a Nikon Eclipse E800 microscope mounted with an Axiocam color CCD camera (Nikon, Melville, NY USA). About 200 to 300 muscle fibers were analyzed per person.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
Antropometric and clinical data for the subjects are summarized in Table 1.
###end p 16
###begin title 17
###xml 44 49 <span type="species:ncbi:9606">human</span>
ATGL protein expression and fiber typing in human skeletal muscle
###end title 17
###begin p 18
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 963 969 963 969 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1090 1091 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1093 1094 1093 1094 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1096 1097 1096 1097 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1127 1128 1127 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1130 1131 1130 1131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1133 1134 1133 1134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1145 1146 1145 1146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1148 1149 1148 1149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1190 1195 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brown</italic>
###xml 1262 1270 1262 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 1273 1274 1273 1274 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1276 1277 1276 1277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1357 1360 1357 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1375 1376 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 1410 1415 1410 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1472 1473 1472 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1544 1545 1544 1545 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1547 1548 1547 1548 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1560 1561 1560 1561 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1563 1564 1563 1564 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 969 1651 969 1651 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">Immunohistochemical ATGL staining combined by immunofluorescent fiber typing in skeletal muscle of a lean (BMI: 21.0 kg/m<sup>2</sup>, <bold>a</bold>, <bold>c</bold>) and an obese (BMI: 32.4 kg/m<sup>2</sup>, <bold>b</bold>, <bold>d</bold>) subject. <bold>a</bold>, <bold>b</bold> Muscle fibers that contain ATGL stained <italic>brown</italic> using DAB (fibers positively stained for ATGL are indicated by an <italic>asterisk</italic>). <bold>c</bold>, <bold>d</bold> Dual-immunofluorescent staining of muscle fibers; type I muscle fibers stained <italic>red</italic> (indicated by <italic>I</italic>), type IIa muscle fibers stained <italic>green</italic> and type IIx muscle fibers were unstained (indicated by <italic>X</italic>). Images are of the same area of the same section from the same lean (<bold>a</bold>, <bold>c</bold>) or obese (<bold>b</bold>, <bold>d</bold>) individual and demonstrate that ATGL is expressed exclusively in type I muscle fibers</p>
###xml 969 1651 969 1651 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">Immunohistochemical ATGL staining combined by immunofluorescent fiber typing in skeletal muscle of a lean (BMI: 21.0 kg/m<sup>2</sup>, <bold>a</bold>, <bold>c</bold>) and an obese (BMI: 32.4 kg/m<sup>2</sup>, <bold>b</bold>, <bold>d</bold>) subject. <bold>a</bold>, <bold>b</bold> Muscle fibers that contain ATGL stained <italic>brown</italic> using DAB (fibers positively stained for ATGL are indicated by an <italic>asterisk</italic>). <bold>c</bold>, <bold>d</bold> Dual-immunofluorescent staining of muscle fibers; type I muscle fibers stained <italic>red</italic> (indicated by <italic>I</italic>), type IIa muscle fibers stained <italic>green</italic> and type IIx muscle fibers were unstained (indicated by <italic>X</italic>). Images are of the same area of the same section from the same lean (<bold>a</bold>, <bold>c</bold>) or obese (<bold>b</bold>, <bold>d</bold>) individual and demonstrate that ATGL is expressed exclusively in type I muscle fibers</p></caption>
###xml 1651 1651 1651 1651 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_386_Fig1_HTML" id="MO1"/>
###xml 963 1651 963 1651 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="19">Immunohistochemical ATGL staining combined by immunofluorescent fiber typing in skeletal muscle of a lean (BMI: 21.0 kg/m<sup>2</sup>, <bold>a</bold>, <bold>c</bold>) and an obese (BMI: 32.4 kg/m<sup>2</sup>, <bold>b</bold>, <bold>d</bold>) subject. <bold>a</bold>, <bold>b</bold> Muscle fibers that contain ATGL stained <italic>brown</italic> using DAB (fibers positively stained for ATGL are indicated by an <italic>asterisk</italic>). <bold>c</bold>, <bold>d</bold> Dual-immunofluorescent staining of muscle fibers; type I muscle fibers stained <italic>red</italic> (indicated by <italic>I</italic>), type IIa muscle fibers stained <italic>green</italic> and type IIx muscle fibers were unstained (indicated by <italic>X</italic>). Images are of the same area of the same section from the same lean (<bold>a</bold>, <bold>c</bold>) or obese (<bold>b</bold>, <bold>d</bold>) individual and demonstrate that ATGL is expressed exclusively in type I muscle fibers</p></caption><graphic position="anchor" xlink:href="418_2008_386_Fig1_HTML" id="MO1"/></fig>
We found that ATGL protein is expressed in skeletal muscle of both lean and obese subjects, respectively (visualized as brown DAB staining in Fig. 1a, b). This observation was representative for all lean (BMI < 25 kg/m2, n = 3) and obese (BMI > 30 kg/m2, n = 5) subjects. Pre-incubation of the ATGL antibody with the ATGL peptide or incubation of the slides without ATGL antibody resulted in the complete disappearance of this staining, indicating that this staining is highly ATGL specific (data not shown). The dual-immunofluorescent staining of skeletal muscle fibers is shown in Fig. 1c (lean subjects) and d (obese subjects). Type I fibers stained red and type IIa fibers stained green; type IIx fibers were unstained. When these images were combined, it appeared that ATGL is expressed exclusively in type I fibers of both lean and obese subjects. All type I fibers stained positive for ATGL. None of the type II fibers showed a positive staining for ATGL. Fig. 1Immunohistochemical ATGL staining combined by immunofluorescent fiber typing in skeletal muscle of a lean (BMI: 21.0 kg/m2, a, c) and an obese (BMI: 32.4 kg/m2, b, d) subject. a, b Muscle fibers that contain ATGL stained brown using DAB (fibers positively stained for ATGL are indicated by an asterisk). c, d Dual-immunofluorescent staining of muscle fibers; type I muscle fibers stained red (indicated by I), type IIa muscle fibers stained green and type IIx muscle fibers were unstained (indicated by X). Images are of the same area of the same section from the same lean (a, c) or obese (b, d) individual and demonstrate that ATGL is expressed exclusively in type I muscle fibers
###end p 18
###begin p 19
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 158 159 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 164 165 164 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 179 180 179 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brown</italic>
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 304 305 304 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 307 308 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 575 576 575 576 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 578 579 578 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 591 592 591 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 594 595 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
Immunohistochemical ATGL staining combined by immunofluorescent fiber typing in skeletal muscle of a lean (BMI: 21.0 kg/m2, a, c) and an obese (BMI: 32.4 kg/m2, b, d) subject. a, b Muscle fibers that contain ATGL stained brown using DAB (fibers positively stained for ATGL are indicated by an asterisk). c, d Dual-immunofluorescent staining of muscle fibers; type I muscle fibers stained red (indicated by I), type IIa muscle fibers stained green and type IIx muscle fibers were unstained (indicated by X). Images are of the same area of the same section from the same lean (a, c) or obese (b, d) individual and demonstrate that ATGL is expressed exclusively in type I muscle fibers
###end p 19
###begin title 20
Discussion
###end title 20
###begin p 21
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
The present study examined ATGL protein expression in human skeletal muscle for the first time. The major finding is that ATGL protein is exclusively expressed in type I oxidative fibers of human skeletal muscle.
###end p 21
###begin p 22
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2001</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2004</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1999</xref>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 489 495 <span type="species:ncbi:9606">humans</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
It is known that type I (slow-twitch, oxidative) muscle fibers have an increased TAG content compared to type IIa and IIx (fast-twitch, oxidative-glycolytic, predominantly glycolytic) fibers (Malenfant et al. 2001). The present finding that ATGL protein is exclusively expressed in type I fibers of human skeletal muscle, characterized by high TAG content compared with type II fibers, may suggest that ATGL plays an important role in intramuscular fatty acid handling and TAG turnover in humans. It has previously been shown that HSL is also expressed in human skeletal muscle (Roepstorff et al. 2004). Although HSL expression is not fiber type specific, higher levels are also found in type I fibers (Langfort et al. 1999). Taken together, the physiological role of ATGL in skeletal muscle lipolysis certainly warrants further investigation, both in healthy volunteers and in obese insulin resistant subjects. It is tempting to speculate that an imbalance between ATGL and HSL expression might increase the storage of TAG or lipid intermediates in skeletal muscle of obese insulin resistant subjects. In addition, it should be examined whether a possible impairment can be reversed by interventions, such as weight loss or physical activity that improve insulin sensitivity.
###end p 22
###begin p 23
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
In summary, the present data show for the first time that ATGL protein is present in human skeletal muscle, and is exclusively expressed in type I muscle fibers. ATGL may play a pivotal role in skeletal muscle fatty acid handling, lipid storage and lipolysis. These data indicate that there is an urgent need to revisit lipolysis in human skeletal muscle.
###end p 23
###begin p 24
The authors greatly appreciated the willingness of the volunteers to participate in this study. This research was supported by a grant from The Netherlands Organisation for Health Research and Development (NWO-ZonMw contract no. 015.01.095) to Prof. Dr. E.E. Blaak.
###end p 24
###begin p 25
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 25
###begin title 26
References
###end title 26
###begin article-title 27
Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects
###end article-title 27
###begin article-title 28
Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development
###end article-title 28
###begin article-title 29
###xml 50 55 <span type="species:ncbi:9606">human</span>
Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation
###end article-title 29
###begin article-title 30
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
###end article-title 30
###begin article-title 31
Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle
###end article-title 31
###begin article-title 32
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Stimulation of hormone-sensitive lipase activity by contractions in rat skeletal muscle
###end article-title 32
###begin article-title 33
Fat content in individual muscle fibers of lean and obese subjects
###end article-title 33
###begin article-title 34
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
###end article-title 34
###begin article-title 35
Etiology of insulin resistance
###end article-title 35
###begin article-title 36
###xml 89 94 <span type="species:ncbi:9606">human</span>
Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise
###end article-title 36
###begin article-title 37
Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase
###end article-title 37

